Navigation Links
Carrington Reports on ISO 9001:2000 Inspection
Date:11/14/2007

- Company's Quality Commitment Continues

- Undisrupted Distribution of CE Marked Products in European Union

IRVING, Texas, Nov. 14 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. (OTC Bulletin Board: CARN) today announced that the Company has completed its annual ISO 9001:2000 re-certification inspection at its Irving, Texas location. The inspection was performed by the European Union's notified body, AMTAC Certification Services, Ltd., a division of Intertek Systems Certification. Earlier in 2007, Carrington's wholly-owned subsidiary in Costa Rica, Sabila Industrial, completed its ISO 9001:2000 re-certification inspection.

Dr. Carlton Turner, president and CEO, stated, "Carrington invests a great amount of resources to ensure its quality standards are upheld. Our quality teams in the U.S. and Costa Rica continue to focus on maintaining and improving the Company's quality systems, which defines the standards of all of our raw materials and finished products.

Sabila Industrial manufactures GelSite(R) polymer, the raw material key to the drug and vaccine delivery technology being developed by Carrington's biotech subsidiary DelSite Biotechnologies, Inc. GelSite(R) is the key polymer to formulate the GelVac(TM) influenza nasal powder vaccine for bird flu (H5N1).

Turner continued, "DelSite's vaccine program and working relations with other bio and pharma companies is based on quality in our manufacturing and development areas. Having all formulations and products developed in an ISO facility and under cGMPs provides a solid foundation for future growth of DelSite and our core business."

Carrington's international customer base includes companies who distribute Carrington products in areas of countries such as Italy, France, Portugal, Serbia-Montenegro; with the expansion into countries such as Cypress, Poland and Turkey.

About Carrington

Carrington Laboratories, Inc. is an ISO 9001-certified,
'/>"/>

SOURCE Carrington Laboratories, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
2. Carrington Reports Second Quarter 2007 Results
3. Carrington Completes $8 Million Financing
4. Carrington Reports on ISO 9001:2000 Inspection at Sabila Industrial in Costa Rica
5. Carrington Subsidiary DelSite Biotechnologies Enters into Technology Evaluation Rights License Agreement for Transdermal Delivery of Vaccines
6. Carrington and DaySpring Pharma Extend and Formalize Agreement for Distribution of Diabetic and Radiation Products Into Physician Market
7. Carrington Laboratories Common Stock Now Trading on the OTC Bulletin Board: CARN.OB
8. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
9. QMed, Inc. Reports July Medicare SNP Enrollments
10. Phlo Affiliate Reports Expanded Coverage to Oregon Border
11. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... -- Cord Blood America, Inc. (OTC Bulletin Board: ... company ( http://www.cordblood-america.com ) focused on bringing ... biological insurance policy, to families nationwide and internationally, ... by a total of $1.4 million so far ... debt eliminated for the year now tops $10 ...
(Date:12/16/2009)... SAN DIEGO, Dec. 16 Sequenom, Inc. ... of Dr. Kenneth Buechler and Mr. David Pendarvis ... http://www.newscom.com/cgi-bin/prnh/20040415/SQNMLOGO ) ,, Kenneth F. Buechler, ... of Biosite Incorporated. From 1988 to 1994, Dr. ... forming Biosite, Dr. Buechler was a senior research ...
(Date:12/16/2009)... Peptone. HSP A has been found to be effectinve in ... ... 16, 2009 -- Nu-Tek BioSciences, LLC. ( www.nu-tekproducts.com ) is meeting ... HSP-A, previously manufactured by Nutricepts, Inc. (Burnsville, Mn), is a high ... and yields. HSP-A has been found to be especially effective ...
(Date:12/15/2009)... WALTHAM, Mass., Dec. 15 Repligen Corporation ... Company has received $731,000 in research funding to ... Friedreich,s ataxia from the Muscular Dystrophy Association (MDA). ... preclinical GLP toxicology testing and GMP manufacture of ... Support from the MDA not only provides important ...
Breaking Biology Technology:Cord Blood America Says 2009 Debt Reduction Tops $10 Million 2Cord Blood America Says 2009 Debt Reduction Tops $10 Million 3Sequenom Appoints Two New Board Members 2Sequenom Appoints Two New Board Members 3Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3
... China, May 6 /Xinhua-PRNewswire-FirstCall/ -- Benda,Pharmaceutical, Inc. ... producing both Gendicine(R), a commercialized gene,therapy medicine ... Chinese and,conventional medicines, today filed an amendment ... Securities and Exchange Commission ("SEC"). The,amendment covers ...
... Inc. (Nasdaq: CALP ) today announced that ... Care Conference in Boston,Massachusetts, will be webcast on ... President and CEO of Caliper, will be providing ... can be accessed at, http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=CALP&item_id=18275 ,63. An archived ...
... Otsuka ... America Pharmaceutical, Inc., ROCKVILLE, Md., May 6 The American ... recipients of the fifth annual APF Awards for Advancing Minority,Mental Health. ... D.C. Each organization or individual was presented a plaque,along with an ...
Other Biology Technology:Benda Pharmaceutical Files Amendment To Form S-1 2American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 2American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 3American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 4American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 5
(Date:12/15/2009)... The 2009 Frost & Sullivan ... presented to Sagem Securite (Safran Group) for ... award recognises the company,s expertise in advanced ... offering novel, value-added products to end users. ... ,, "Sagem Securite has been involved in ...
(Date:12/15/2009)... brain diseases such as Alzheimer,s and Parkinson,s, doctors can ... help a patient. , But they come up empty-handed ... patients with ataxia disabling disorders that rob people ... neurologists are trying to change that with the help ... Institute of Neurological Disorders and Stroke to establish a ...
(Date:12/15/2009)... environmental impacts, social dynamics, and production levels are ... of an agroecosystem. Positive or negative, these factors ... social groups to continuously adapt farming and food ... learning theory suggests that knowledge is gained as ... are especially valuable for environmental and agricultural educators ...
Breaking Biology News(10 mins):Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 2Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 3Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 4UF to lead national effort to help patients with rare brain disease 2UF to lead national effort to help patients with rare brain disease 3Experiential learning teaches change and adaptation 2Carnegie Mellon Researchers Develop Novel Tool to Rank Death Rates 55462 1Carnegie Mellon Researchers Develop Novel Tool to Rank Death Rates 55462 2Carnegie Mellon Researchers Develop Novel Tool to Rank Death Rates 55462 3Carnegie Mellon Researchers Develop Novel Tool to Rank Death Rates 55462 4UPDATE 3A Spokane Washington Man Indicted on Civil Rights Charges Related to Threats to Reproductive Health Services Clinic 55459 1California Life Science Business and Economic Development Experts Discuss Californias Bioscience Future 13708 1California Life Science Business and Economic Development Experts Discuss Californias Bioscience Future 13708 2
... Cincinnati, OH, August 13, 2008Dairy is recognized as a key ... it was unclear how long-term dairy intake contributes to the ... bone mineral content, and bone area. A new study ... investigates the effect of childhood dairy intake on adolescent ...
... hepatitis B infects 400 million people worldwide, many of ... B remains a stubborn, unrelenting health problem, especially in ... complications cause an estimated 1 million deaths globally each ... required for the current vaccines are costly and hard ...
... Ind. - Researchers have discovered an unusual molecule ... break down pollutants, especially the compounds that cause ... by this molecule, however, that will attract the ... University of Pennsylvania,s Edmund J. Kahn Distinguished Professor, ...
Other Biology News:Childhood dairy intake may improve adolescent bone health 2Nano vaccine for hepatitis B shows promise for third world 2Nano vaccine for hepatitis B shows promise for third world 3Strange molecule in the sky cleans acid rain, scientists discover 2Strange molecule in the sky cleans acid rain, scientists discover 3
...
... Spin Columns provide a rapid and simple method ... bp to 10 kb) from stained agarose gels ... excised from an agarose gel and loaded into ... the column are a series of membranes and ...
... The SpinPrep Gel DNA Kit enables efficient extraction ... bp in size from agarose gels. The procedure uses ... adsorption of the DNA to a silica membrane in ... purified DNA is eluted in low-salt buffer. Each spin ...
When added to either StemSep CD4+ or CD8+ T Cell Enrichment cocktails, human HLA-DR TAC is designed to deplete human HLA-DR from samples to isolate resting CD4+ or CD8+ T cells....
Biology Products: